Larvol Delta - Evaluation-of-the-Safety-and-Efficacy-of-ALSL1023-Administered-in-Combination-With-Ranibizumab-in-Patients-With-WetAMD

lemon balm extract (ALS-L1023) - Hanmi, AngioLab

Lucentis (ranibizumab) - Roche, Novartis

http://clinicaltrials.gov/ct2/show/NCT03725501

Jan 13, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next